These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22138144)

  • 1. Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk.
    Phillips CM; Kesse-Guyot E; Ahluwalia N; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    Atherosclerosis; 2012 Feb; 220(2):513-9. PubMed ID: 22138144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    Atherosclerosis; 2011 Feb; 214(2):408-14. PubMed ID: 21122859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Mehegan J; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1386-94. PubMed ID: 20080841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study.
    Shab-Bidar S; Hosseini-Esfahani F; Mirmiran P; Hosseinpour-Niazi S; Azizi F
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():98-108. PubMed ID: 23731333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome.
    Phillips CM; Goumidi L; Bertrais S; Ferguson JF; Field MR; Kelly ED; Peloso GM; Cupples LA; Shen J; Ordovas JM; McManus R; Hercberg S; Portugal H; Lairon D; Planells R; Roche HM
    Am J Clin Nutr; 2009 Dec; 90(6):1665-73. PubMed ID: 19828715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome is associated with and predicted by resting heart rate: a cross-sectional and longitudinal study.
    Jiang X; Liu X; Wu S; Zhang GQ; Peng M; Wu Y; Zheng X; Ruan C; Zhang W
    Heart; 2015 Jan; 101(1):44-9. PubMed ID: 25179964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
    Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
    Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C3 as a marker of cardiometabolic risk in psoriasis.
    Torres T; Bettencourt N; Mendonça D; Vasconcelos C; Silva BM; Selores M
    Arch Dermatol Res; 2014 Sep; 306(7):653-60. PubMed ID: 24848273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk.
    Salazar MR; Carbajal HA; Espeche WG; Dulbecco CA; Aizpurúa M; Marillet AG; Echeverría RF; Reaven GM
    Diab Vasc Dis Res; 2011 Apr; 8(2):109-16. PubMed ID: 21562062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity phenotypes and risk of cardiovascular disease in a decade of follow-up: the Tehran Lipid and Glucose Study.
    Keihani S; Hosseinpanah F; Barzin M; Serahati S; Doustmohamadian S; Azizi F
    Atherosclerosis; 2015 Feb; 238(2):256-63. PubMed ID: 25540856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of metabolic syndrome with smoking and alcohol intake in Japanese men.
    Takeuchi T; Nakao M; Nomura K; Yano E
    Nicotine Tob Res; 2009 Sep; 11(9):1093-8. PubMed ID: 19596726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate replacement of carbohydrates by dietary fats affects features of metabolic syndrome: a randomized crossover clinical trial.
    Rajaie S; Azadbakht L; Khazaei M; Sherbafchi M; Esmaillzadeh A
    Nutrition; 2014 Jan; 30(1):61-8. PubMed ID: 24290600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adults.
    Puchau B; Zulet MA; González de Echávarri A; Navarro-Blasco I; Martínez JA
    Eur J Clin Nutr; 2009 Jul; 63(7):858-64. PubMed ID: 18985060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes.
    Peake PW; Kriketos AD; Campbell LV; Charlesworth JA
    Int J Obes (Lond); 2005 Apr; 29(4):429-35. PubMed ID: 15111984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triacylglycerols and body fat mass are possible independent predictors of C3 in apparently healthy young Brazilian adults.
    Volp AC; Barbosa KB; Bressan J
    Nutrition; 2012 May; 28(5):544-50. PubMed ID: 22206689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study.
    Miot A; Maimaitiming S; Emery N; Bellili N; Roussel R; Tichet J; Velho G; Balkau B; Marre M; Fumeron F;
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2942-7. PubMed ID: 20382686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human plasma complement C3 is independently associated with coronary heart disease, but only in heavy smokers (the CODAM study).
    van Greevenbroek MM; Jacobs M; van der Kallen CJ; Blaak EE; Jansen EH; Schalkwijk CG; Feskens EJ; Stehouwer CD
    Int J Cardiol; 2012 Jan; 154(2):158-62. PubMed ID: 20926148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat.
    Phillips CM; Goumidi L; Bertrais S; Field MR; Cupples LA; Ordovas JM; McMonagle J; Defoort C; Lovegrove JA; Drevon CA; Blaak EE; Kiec-Wilk B; Riserus U; Lopez-Miranda J; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
    J Lipid Res; 2010 Dec; 51(12):3500-7. PubMed ID: 20855566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.